Cargando…
The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease
BACKGROUND AND AIMS: The human gastrointestinal tract harbours distinct microbial communities essential for health. Little is known about small intestinal communities, despite the small intestine playing a fundamental role in nutrient absorption and host-microbe immune homeostasis. We aimed to explo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328293/ https://www.ncbi.nlm.nih.gov/pubmed/33515008 http://dx.doi.org/10.1093/ecco-jcc/jjab020 |
_version_ | 1783732277395587072 |
---|---|
author | Ruigrok, Renate A A A Collij, Valerie Sureda, Paula Klaassen, Marjolein A Y Bolte, Laura A Jansen, Bernadien H Voskuil, Michiel D Fu, Jingyuan Wijmenga, Cisca Zhernakova, Alexandra Weersma, Rinse K Vich Vila, Arnau |
author_facet | Ruigrok, Renate A A A Collij, Valerie Sureda, Paula Klaassen, Marjolein A Y Bolte, Laura A Jansen, Bernadien H Voskuil, Michiel D Fu, Jingyuan Wijmenga, Cisca Zhernakova, Alexandra Weersma, Rinse K Vich Vila, Arnau |
author_sort | Ruigrok, Renate A A A |
collection | PubMed |
description | BACKGROUND AND AIMS: The human gastrointestinal tract harbours distinct microbial communities essential for health. Little is known about small intestinal communities, despite the small intestine playing a fundamental role in nutrient absorption and host-microbe immune homeostasis. We aimed to explore the small intestine microbial composition and metabolic potential, in the context of inflammatory bowel disease [IBD]. METHODS: Metagenomes derived from faecal samples and extensive phenotypes were collected from 57 individuals with an ileostomy or ileoanal pouch, and compared with 1178 general population and 478 IBD faecal metagenomes. Microbiome features were identified using MetaPhAn2 and HUMAnN2, and association analyses were performed using multivariate linear regression. RESULTS: Small intestinal samples had a significantly lower bacterial diversity, compared with the general population and, to a lesser extent, IBD samples. Comparing bacterial composition, small intestinal samples clustered furthest from general population samples and closest to IBD samples with intestinal resections. Veillonella atypica, Streptococcus salivarius, and Actinomyces graevenitzii were among the species significantly enriched in the small intestine. Predicted metabolic pathways in the small intestine are predominantly involved in simple carbohydrate and energy metabolism, but also suggest a higher pro-inflammatory potential. CONCLUSIONS: We described the bacterial composition and metabolic potential of the small intestinal microbiota. The colonic microbiome of IBD patients, particularly with intestinal resections, showed resemblance to that of the small intestine. Moreover, several features characterising the small intestinal microbiome have been previously associated with IBD. These results highlight the importance of studying the small intestinal microbiota to gain new insight into disease pathogenesis. |
format | Online Article Text |
id | pubmed-8328293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83282932021-08-03 The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease Ruigrok, Renate A A A Collij, Valerie Sureda, Paula Klaassen, Marjolein A Y Bolte, Laura A Jansen, Bernadien H Voskuil, Michiel D Fu, Jingyuan Wijmenga, Cisca Zhernakova, Alexandra Weersma, Rinse K Vich Vila, Arnau J Crohns Colitis Original Articles BACKGROUND AND AIMS: The human gastrointestinal tract harbours distinct microbial communities essential for health. Little is known about small intestinal communities, despite the small intestine playing a fundamental role in nutrient absorption and host-microbe immune homeostasis. We aimed to explore the small intestine microbial composition and metabolic potential, in the context of inflammatory bowel disease [IBD]. METHODS: Metagenomes derived from faecal samples and extensive phenotypes were collected from 57 individuals with an ileostomy or ileoanal pouch, and compared with 1178 general population and 478 IBD faecal metagenomes. Microbiome features were identified using MetaPhAn2 and HUMAnN2, and association analyses were performed using multivariate linear regression. RESULTS: Small intestinal samples had a significantly lower bacterial diversity, compared with the general population and, to a lesser extent, IBD samples. Comparing bacterial composition, small intestinal samples clustered furthest from general population samples and closest to IBD samples with intestinal resections. Veillonella atypica, Streptococcus salivarius, and Actinomyces graevenitzii were among the species significantly enriched in the small intestine. Predicted metabolic pathways in the small intestine are predominantly involved in simple carbohydrate and energy metabolism, but also suggest a higher pro-inflammatory potential. CONCLUSIONS: We described the bacterial composition and metabolic potential of the small intestinal microbiota. The colonic microbiome of IBD patients, particularly with intestinal resections, showed resemblance to that of the small intestine. Moreover, several features characterising the small intestinal microbiome have been previously associated with IBD. These results highlight the importance of studying the small intestinal microbiota to gain new insight into disease pathogenesis. Oxford University Press 2021-01-30 /pmc/articles/PMC8328293/ /pubmed/33515008 http://dx.doi.org/10.1093/ecco-jcc/jjab020 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Ruigrok, Renate A A A Collij, Valerie Sureda, Paula Klaassen, Marjolein A Y Bolte, Laura A Jansen, Bernadien H Voskuil, Michiel D Fu, Jingyuan Wijmenga, Cisca Zhernakova, Alexandra Weersma, Rinse K Vich Vila, Arnau The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease |
title | The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease |
title_full | The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease |
title_fullStr | The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease |
title_full_unstemmed | The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease |
title_short | The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease |
title_sort | composition and metabolic potential of the human small intestinal microbiota within the context of inflammatory bowel disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328293/ https://www.ncbi.nlm.nih.gov/pubmed/33515008 http://dx.doi.org/10.1093/ecco-jcc/jjab020 |
work_keys_str_mv | AT ruigrokrenateaaa thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT collijvalerie thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT suredapaula thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT klaassenmarjoleinay thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT boltelauraa thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT jansenbernadienh thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT voskuilmichield thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT fujingyuan thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT wijmengacisca thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT zhernakovaalexandra thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT weersmarinsek thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT vichvilaarnau thecompositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT ruigrokrenateaaa compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT collijvalerie compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT suredapaula compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT klaassenmarjoleinay compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT boltelauraa compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT jansenbernadienh compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT voskuilmichield compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT fujingyuan compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT wijmengacisca compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT zhernakovaalexandra compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT weersmarinsek compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease AT vichvilaarnau compositionandmetabolicpotentialofthehumansmallintestinalmicrobiotawithinthecontextofinflammatoryboweldisease |